Treatment
Treatment clinical trials
We’re tracking 8,333 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT05752604Recruiting
Study of treatments and factors in thyroid cancer
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
MilanAges Any age - NCT06439654Recruiting
Optimizing cholesterol treatment for heart health
This trial helps people with high cholesterol or a history of heart disease find the best treatment to lower their risk of future heart problems. It tests a program to optimize lipid-lowering therapy.
Clark, New JerseyAges 18–120 - NCT06724861Recruiting
Sensory rehabilitation for chemo-related nerve pain
This trial is testing a sensory rehabilitation program for people who have ongoing nerve pain or numbness in their hands or feet after chemotherapy. It aims to help improve sensation and movement.
TzrifinAges 18 years+ - NCT06726122Enrolling by invitation
Matrix Pro skin treatment study for ages 18-84
This study tests a new device called Matrix Pro that uses Profound Matrix technology to treat skin concerns. It aims to see if the treatment is safe and works well for people with different skin types.
Amsterdam, EKAges 18–84 - NCT06717295Recruiting
Blood test to find cancer early and track treatment
This study uses a blood test that looks at your platelets and immune cells to find common cancers early, and for certain cancers, to monitor how well treatment is working.
RosarioAges 40–75 - NCT06726785Recruiting
Gene changes in nasal cells of RLS patients on long-term dopamine agonist
This study looks at changes in a gene (DRD2) in nasal cells of people with Restless Legs Syndrome who are taking a dopamine agonist medication for a long time. It aims to understand how this gene might be involved in RLS.
San Francisco, CaliforniaAges 18–60 - NCT06721962RecruitingPhase 1/Phase 2
Testing an experimental treatment for moderate to severe Crohn's disease
This trial is testing a new investigational treatment called TRX103 for adults with moderate to severe Crohn's disease that has not responded to at least two other advanced therapies. The study aims to see if this treatment can reduce inflammation and improve symptoms.
Scottsdale, ArizonaAges 18–65 - NCT06290167Recruiting
Dual-task rehab for memory concerns in older adults
This study tests a new rehab program that combines physical and mental tasks for older adults with early memory issues. It aims to help improve daily function and possibly slow decline.
Milan, MIAges 65 years+ - NCT05849740RecruitingPhase 4
CD38 antibody plus steroid for acquired hemophilia A
This trial studies whether a CD38-targeting antibody together with corticosteroids can improve outcomes in acquired hemophilia A. It is an “exploratory” Phase 4 study, meaning the goal is to learn more about safety and effectiveness in real-world patients.
TianjinAges 18 years+ - NCT06726577RecruitingPhase 1/Phase 2
A new drug for ALS: phase 1/2 safety and effectiveness trial
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
Suzhou, JiangsuAges 18 years+ - NCT06717711RecruitingPhase 3
Shockwave therapy for penis recovery after prostate cancer surgery
This trial tests if low-intensity shockwaves can help men regain erectile function after robot-assisted prostate surgery. If you had nerve-sparing surgery and have good erections before treatment, this may help you recover faster.
Rome, RMAges 18–75 - NCT06724224Recruiting
Comparing thyroid hormone drugs for babies with low thyroid
This study compares two types of levothyroxine (a thyroid hormone medicine) to see which works better for newborns and children with congenital hypothyroidism (a condition where the thyroid gland doesn't work properly from birth). If your child was diagnosed early and lives in the Emilia-Romagna region of Italy, this trial may help find the best treatment.
Bologna, BolognaAges Up to 11 years - NCT06718010Recruiting
Blood markers and breast cancer treatment results
This study looks at how age-related changes in your blood might affect how well your breast cancer treatment works. It includes people with hormone receptor-positive, HER2-negative breast cancer that has not spread to distant organs.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06722027Recruiting
Spiritual health program for healthcare teams
This study looks at whether a program focused on spiritual health can help healthcare teams feel less stressed and more connected. It is for employees working in cancer care or intensive care at Emory.
Atlanta, GeorgiaAges 18 years+ - NCT06719206Recruiting
Reducing sitting time during cancer treatment
This study looks at helping people with breast, prostate, or colorectal cancer who are starting or have recently started treatment (like chemo or radiation) to sit less and move more during their treatment. If you are treated at a hospital in Uppsala or Västerås, Sweden, you may be able to join.
UppsalaAges 18 years+ - NCT06721754Recruiting
Negative pressure therapy for diabetic foot ulcers
This study tests if a vacuum-like wound dressing (negative pressure wound therapy) helps heal diabetic foot ulcers after surgery. It may be a good fit if you have a foot ulcer needing surgery and are able to walk.
Oslo, NordbyhagenAges 18 years+ - NCT06716658RecruitingPhase 2
New targeted drug for certain T/NK-cell lymphomas
This trial tests an oral JAK1 inhibitor called golidocitnib for people with T/NK-cell lymphoma that came back after treatment or didn't respond. The drug works by blocking a signal that helps cancer cells grow.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06724965Recruiting
Trauma treatment and PrEP support for transgender and nonbinary adults
This study combines a proven trauma treatment (STAIR) with peer-led PrEP navigation to help transgender and nonbinary people cope with stress and stay HIV-free. It aims to improve mental health and increase PrEP use.
Los Angeles, CaliforniaAges 18 years+ - NCT06719700RecruitingPhase 2
Chemo-radiation with two drugs for limited-stage small cell lung cancer
This trial tests combining standard chemotherapy with radiation (chemoradiotherapy) plus two additional drugs, toripalimab and surufatinib, for people with limited-stage small cell lung cancer. The goal is to see if this combination improves outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06725095Enrolling by invitation
Enamel gel for gum inflammation around dental implants
This study tests whether a special enamel gel can reduce inflammation around dental implants. It might help if your implant has bleeding gums but no deeper infection.
Catania, CtAges 18–75 - NCT06722586RecruitingPhase 4
Sirolimus alone for low platelet counts from antiphospholipid antibodies
This trial tests if sirolimus, a medicine that calms the immune system, can safely raise platelet counts in people with antiphospholipid antibodies and persistently low platelets. It may be an option if other treatments haven't worked or you want a simpler drug plan.
Changsha, HunanAges 18 years+ - NCT06716866Enrolling by invitation
Electric field stimulation for epilepsy
This trial tests a new type of brain stimulation using electric fields to treat epilepsy, specifically for people who are already having invasive EEG monitoring as part of their care.
Sacramento, CaliforniaAges 18 years+ - NCT06719622Enrolling by invitationPhase 2/Phase 3
Budesonide for Crohn's in the upper gut
This trial tests a budesonide liquid that targets inflammation in the esophagus, stomach, and duodenum (upper digestive tract) in children with Crohn's disease. It aims to see if this treatment can reduce inflammation in those areas without strong side effects.
KrakowAges 6–18 - NCT06720142Recruiting
Magnesium bone filler study after tumor or trauma surgery
This study looks at how well a magnesium-based bone filler (Mg OSTEOCRETE) works for people who need it after bone tumor removal, to fix loose implants, or to help heal bone from injuries. Researchers want to track outcomes to see how helpful it is.
Boston, MassachusettsAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,333 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.